Octave Specialty Group (NYSE:OSG) Shares Break Above 200 Day Moving Average - Time to Sell?

Key Points

• Shares moved above their 200-day moving average, trading as high as $5.42 and last at $5.335, compared with the average of $5.19.
• Analyst views are mixed: the consensus rating is Hold, with an average price target of $8.00; ratings range from Buy to Sell.
• Quarterly results beat estimates, with a loss of $0.03 per share versus the expected $0.05 loss and revenue of $85.34 million versus $23.22 million expected. The company nevertheless reported a negative net margin of 19.17%.

Octave Specialty Group, Inc. (NYSE:OSG - Get Free Report)'s share price passed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $5.19 and traded as high as $5.42. Octave Specialty Group shares last traded at $5.3350, with a volume of 429,749 shares changing hands.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on OSG. Weiss Ratings downgraded shares of Octave Specialty Group from a "sell (d-)" rating to a "sell (e+)" rating in a report on Monday. Zacks Research raised Octave Specialty Group from a "strong sell" rating to a "hold" rating in a report on Tuesday, November 3rd. Finally, Keefe, Bruyette & Woods initiated coverage on Octave Specialty Group in a report on Friday, August 28th. They set an "outperform" rating and a $8.00 price objective on the stock. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Octave Specialty Group has a consensus rating of "Hold" and an average price target of $8.00.

Octave Specialty Group Price Performance

The company has a market capitalization of $240.34 million, a price-to-earnings ratio of -3.31 and a beta of 0.76. The company has a quick ratio of 0.92, a current ratio of 0.93 and a debt-to-equity ratio of 0.19. The stock's 50-day moving average price is $4.75 and its 200-day moving average price is $5.19.

Octave Specialty Group (NYSE:OSG - Get Free Report) last announced its quarterly earnings data on Monday, November 9th. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. Octave Specialty Group had a positive return on equity of 1.51% and a negative net margin of 19.17%. The firm had revenue of $85.34 million during the quarter, compared to analysts' expectations of $23.22 million. Equities research analysts anticipate that Octave Specialty Group, Inc. will post 0.22 earnings per share for the current year.

Institutional Trading of Octave Specialty Group

Hedge funds and other institutional investors have recently made changes to their positions in the business. Parallel Advisors LLC grew its stake in Octave Specialty Group by 4,186.8% in the first quarter. Parallel Advisors LLC now owns 6,473 shares of the company's stock valued at $30,000 after purchasing an additional 6,322 shares in the last quarter. Versant Capital Management Inc bought a new stake in shares of Octave Specialty Group in the second quarter valued at about $52,000. Advisors Asset Management Inc. acquired a new position in shares of Octave Specialty Group during the 3rd quarter worth approximately $50,000. Corient Private Wealth LP bought a new stake in shares of Octave Specialty Group during the 2nd quarter valued at $77,000. Finally, Vise Technologies Inc. bought a new position in Octave Specialty Group in the 3rd quarter valued at about $54,000. 80.92% of the stock is currently owned by institutional investors and hedge funds.

Octave Specialty Group Company Profile

Octave Specialty Group is a specialty insurance platform focused on underwriting and distributing insurance products for niche markets. Its business connects insurance carriers, brokers and policyholders through specialized insurance operations. The company's activities include specialty underwriting and insurance distribution, serving risks that may require coverage beyond standard insurance offerings. Detailed information about its specific product lines, geographic reach and leadership was not available to confirm.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.